Date published: 2026-5-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

ADAMTS-8 Activators

A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) is a family of proteolytic enzymes that play crucial roles in the regulation of the extracellular matrix (ECM) and cellular signaling. ADAMTS-8, a specific member of this family, functions primarily in the cleavage of specific substrates within the ECM, thereby affecting processes like cell adhesion, migration, and signaling. Its activity is regulated by various factors, such as protein-protein interactions, substrate availability, and post-translational modifications. In addition, its expression can be modulated by various signaling pathways, including but not limited to, TGF-β, Notch, and PDGF. ADAMTS-8 expression and activity can also be influenced by the cellular microenvironment, including oxidative stress conditions and the availability of various ions and cofactors. Through these interactions, ADAMTS-8 indirectly influences a multitude of physiological processes, ranging from tissue remodeling to cellular differentiation and proliferation.

ADAMTS-8 Activators do not necessarily interact directly with ADAMTS-8 but may exert their effects indirectly by modulating opposing pathways, altering epigenetic regulation, or affecting substrate availability. For example, some of these activators might be inhibitors of pathways that suppress ADAMTS-8 expression, such as TGF-β inhibitors. Others, like HDAC inhibitors, could change the epigenetic landscape favorably for ADAMTS-8 expression. Another approach to activation is through stabilizing the ECM, which serves as the substrate for ADAMTS-8; this could be achieved by molecules that inhibit enzymes responsible for ECM degradation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

As a TGF-β inhibitor, it could potentially upregulate ADAMTS-8 by preventing its downregulation. TGF-β signaling often suppresses ADAMTS-8 expression.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

This HDAC inhibitor may promote ADAMTS-8 gene expression by altering the epigenetic landscape.

Dimethyloxaloylglycine (DMOG)

89464-63-1sc-200755
sc-200755A
sc-200755B
sc-200755C
10 mg
50 mg
100 mg
500 mg
$84.00
$301.00
$374.00
$779.00
25
(2)

This hydroxylase inhibitor could affect post-translational modifications of ADAMTS-8, influencing its stability or activity.

N-Acetyl-L-cysteine

616-91-1sc-202232
sc-202232A
sc-202232C
sc-202232B
5 g
25 g
1 kg
100 g
$34.00
$74.00
$270.00
$114.00
34
(1)

As a ROS scavenger, it could potentially activate ADAMTS-8 by reducing oxidative stress.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$40.00
$120.00
$480.00
$2141.00
47
(3)

A gamma-secretase inhibitor that interferes with Notch signaling could indirectly influence ADAMTS-8 expression or activity.